Literature DB >> 15031718

Activation of Rho in the injured axons following spinal cord injury.

Tomas Madura1, Toshihide Yamashita, Tateki Kubo, Masashi Fujitani, Ko Hosokawa, Masaya Tohyama.   

Abstract

Axons of the adult central nervous system have very limited ability to regenerate after injury. This inability may be, at least partly, attributable to myelin-derived proteins, such as myelin-associated glycoprotein, Nogo and oligodendrocyte myelin glycoprotein. Recent evidence suggests that these proteins inhibit neurite outgrowth by activation of Rho through the neurotrophin receptor p75(NTR)/Nogo receptor complex. Despite rapidly growing knowledge on these signals at the molecular level, it remained to be determined whether Rho is activated after injury to the central nervous system. To assess this question, we establish a new method to visualize endogenous Rho activity in situ. After treatment of cerebellar granular neurons with the Nogo peptide in vitro, Rho is spatially activated and colocalizes with p75(NTR). Following spinal cord injury in vivo, massive activation of Rho is observed in the injured neurites. Spatial regulation of Rho activity may be necessary for axonal regulation by the inhibitory cues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031718      PMCID: PMC1299028          DOI: 10.1038/sj.embor.7400117

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  19 in total

1.  Inactivation of Rho signaling pathway promotes CNS axon regeneration.

Authors:  M Lehmann; A Fournier; I Selles-Navarro; P Dergham; A Sebok; N Leclerc; G Tigyi; L McKerracher
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 2.  Neurotrophins: neurotrophic modulation of neurite growth.

Authors:  A M Davies
Journal:  Curr Biol       Date:  2000-03-09       Impact factor: 10.834

3.  Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI.

Authors:  Miguel Angel Del Pozo; William B Kiosses; Nazilla B Alderson; Nahum Meller; Klaus M Hahn; Martin Alexander Schwartz
Journal:  Nat Cell Biol       Date:  2002-03       Impact factor: 28.824

4.  Regulation of rho GTPases by crosstalk and neuronal activity in vivo.

Authors:  Zheng Li; Carlos D Aizenman; Hollis T Cline
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

5.  Measurement of GTP-bound Ras-like GTPases by activation-specific probes.

Authors:  M van Triest; J de Rooij; J L Bos
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

Review 6.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch.

Authors:  Anja Schmidt; Alan Hall
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

7.  Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.

Authors:  A Ho; S R Schwarze; S J Mermelstein; G Waksman; S F Dowdy
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

8.  Rho signaling pathway targeted to promote spinal cord repair.

Authors:  Pauline Dergham; Benjamin Ellezam; Charles Essagian; Hovsep Avedissian; William D Lubell; Lisa McKerracher
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

9.  Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.

Authors:  Kevin C Wang; Vuk Koprivica; Jieun A Kim; Rajeev Sivasankaran; Yong Guo; Rachel L Neve; Zhigang He
Journal:  Nature       Date:  2002-06-16       Impact factor: 49.962

10.  The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho.

Authors:  Toshihide Yamashita; Haruhisa Higuchi; Masaya Tohyama
Journal:  J Cell Biol       Date:  2002-05-13       Impact factor: 10.539

View more
  31 in total

1.  RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model.

Authors:  So-Jung Gwak; Christian Macks; Da Un Jeong; Mark Kindy; Michael Lynn; Ken Webb; Jeoung Soo Lee
Journal:  Biomaterials       Date:  2017-01-03       Impact factor: 12.479

2.  Cellular expression profile of RhoA in rats with spinal cord injury.

Authors:  Wen-Jie Wei; Zhi-Yuan Yu; Huai-Jie Yang; Min-Jie Xie; Wei Wang; Xiang Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

3.  The role of RhoA in retrograde neuronal death and axon regeneration after spinal cord injury.

Authors:  Jianli Hu; Guixin Zhang; William Rodemer; Li-Qing Jin; Michael Shifman; Michael E Selzer
Journal:  Neurobiol Dis       Date:  2016-11-22       Impact factor: 5.996

4.  A novel role for PTEN in the inhibition of neurite outgrowth by myelin-associated glycoprotein in cortical neurons.

Authors:  Ana Luisa Perdigoto; Nagarathnamma Chaudhry; Gregory N Barnes; Marie T Filbin; Bruce D Carter
Journal:  Mol Cell Neurosci       Date:  2010-09-30       Impact factor: 4.314

Review 5.  Chemical priming for spinal cord injury: a review of the literature. Part I-factors involved.

Authors:  Martin M Mortazavi; Ketan Verma; Aman Deep; Fatemeh B Esfahani; Patrick R Pritchard; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-12-18       Impact factor: 1.475

6.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

7.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.

Authors:  Sarah E James; Hubert Burden; Russell Burgess; Youmei Xie; Tao Yang; Stephen M Massa; Frank M Longo; Qun Lu
Journal:  Neurotoxicology       Date:  2008-04-26       Impact factor: 4.294

9.  Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

Authors:  Sarah E James; Mayisha Dunham; Monica Carrion-Jones; Alexander Murashov; Qun Lu
Journal:  Neurotoxicology       Date:  2010-01-08       Impact factor: 4.294

10.  Assessment of Nogo-66 receptor 1 function in vivo after spinal cord injury.

Authors:  Jing Tong; Yi Ren; Xiaowei Wang; Vassilios G Dimopoulos; Henry N Kesler; Weimin Liu; Xiaosheng He; Maiken Nedergaard; Jason H Huang
Journal:  Neurosurgery       Date:  2014-07       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.